These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7571955)

  • 1. Atrophic vaginitis and urinary symptoms in postmenopausal women.
    Rammou-Kinia R; Anagnostopoulou I
    Acta Cytol; 1995; 39(5):1073. PubMed ID: 7571955
    [No Abstract]   [Full Text] [Related]  

  • 2. Atrophic vaginitis: signs, symptoms, and better outcomes.
    Reimer A; Johnson L
    Nurse Pract; 2011 Jan; 36(1):22-8; quiz 29. PubMed ID: 21150811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of atrophic vaginitis.
    Bachmann GA; Nevadunsky NS
    Am Fam Physician; 2000 May; 61(10):3090-6. PubMed ID: 10839558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of post-menopausal vaginal atrophy and atrophic vaginitis.
    Castelo-Branco C; Cancelo MJ; Villero J; Nohales F; Juliá MD
    Maturitas; 2005 Nov; 52 Suppl 1():S46-52. PubMed ID: 16139449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal administration of low-dose conjugated estrogens: systemic absorption and effects on the endometrium.
    Handa VL; Bachus KE; Johnston WW; Robboy SJ; Hammond CB
    Obstet Gynecol; 1994 Aug; 84(2):215-8. PubMed ID: 8041532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label randomized trial to determine the most effective regimen of vaginal estrogen to reduce the prevalence of atrophic changes reported in postmenopausal cervical smears.
    Bateson DJ; Weisberg E
    Menopause; 2009; 16(4):765-9. PubMed ID: 19407678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis.
    Chollet JA; Carter G; Meyn LA; Mermelstein F; Balk JL
    Menopause; 2009; 16(5):978-83. PubMed ID: 19390463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrophic vaginitis versus invasive squamous cell carcinoma on ThinPrep cytology: can the background be reliably distinguished?
    Selvaggi SM
    Diagn Cytopathol; 2002 Dec; 27(6):362-4. PubMed ID: 12451567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. By the way, doctor. My gynecologist says that I have atrophic vaginitis and that it's a common problem for menopausal women. In all my reading about menopause, I've never come across this condition. What can you tell me about it?
    Harv Womens Health Watch; 2002 Feb; 9(6):7. PubMed ID: 14521132
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaginitis.
    Smibert J
    Aust Fam Physician; 1976 Sep; 5(8):1131-2, 1135-6, 1141-3 passim. PubMed ID: 802969
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyaluronic acid in the treatment of postmenopausal women with atrophic vaginitis.
    Karaosmanoglu O; Cogendez E; Sozen H; Asoglu MR; Akdemir Y; Eren S
    Int J Gynaecol Obstet; 2011 May; 113(2):156-7. PubMed ID: 21420087
    [No Abstract]   [Full Text] [Related]  

  • 12. NITROFURAZONE-ESTROGEN VAGINAL SUPPOSITORIES IN THE TREATMENT OF ATROPHIC VAGINITIS.
    FRIEDMAN JA; OLSEN N
    J Am Geriatr Soc; 1965 Sep; 13():828-31. PubMed ID: 14341031
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical profile and cervical cytomorphology in symptomatic postmenopausal women.
    Thomas A; Correa MM; Kumar KR
    Indian J Pathol Microbiol; 2003 Apr; 46(2):176-9. PubMed ID: 15022903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.
    Bachmann G; Lobo RA; Gut R; Nachtigall L; Notelovitz M
    Obstet Gynecol; 2008 Jan; 111(1):67-76. PubMed ID: 18165394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic cytology of nonspecific vaginitis.
    Giacomini G; Reali D; Vita D; Barahmandpour S; D'Acunto A
    Diagn Cytopathol; 1987 Sep; 3(3):198-205. PubMed ID: 3665689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal vaginal atrophy correlates with decreased estradiol and body mass index and does not depend on the time since menopause.
    Repse-Fokter A; Takac I; Fokter SK
    Gynecol Endocrinol; 2008 Jul; 24(7):399-404. PubMed ID: 18645712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy.
    Dugal R; Hesla K; Sørdal T; Aase KH; Lilleeidet O; Wickstrøm E
    Acta Obstet Gynecol Scand; 2000 Apr; 79(4):293-7. PubMed ID: 10746845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of urinary incontinence in a prospective cohort of postmenopausal women.
    Jackson SL; Scholes D; Boyko EJ; Abraham L; Fihn SD
    Obstet Gynecol; 2006 Oct; 108(4):855-62. PubMed ID: 17012446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytologic examination of vaginal smears in postmenopausal women undergoing ethinyl estradiol treatment].
    Damholt V
    Nord Med; 1968 Mar; 79(12):385-8. PubMed ID: 4872510
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
    Chompootaweep S; Nunthapisud P; Trivijitsilp P; Sentrakul P; Dusitsin N
    Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.